Morningside Venture Investments Ltd's Net Worth
Estimate Recalculated Nov 7, 2024 05:16PM EST
Who is Morningside Venture Investments Ltd
Morningside Venture Investments Ltd has an estimated net worth of $492 Million. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., GreenLight Biosciences Holdings, PBC, Kezar Life Sciences, Inc., Apellis Pharmaceuticals, Inc., Liquidia Technologies Inc, and ARGOS THERAPEUTICS INC.
SEC CIK
Morningside Venture Investments Ltd's CIK is 0001543112
Past Insider Trading and Trends
2018 was Morningside Venture Investments Ltd's most active year for acquiring shares with 10 total transactions. Morningside Venture Investments Ltd's most active month to acquire stocks was the month of August. 2023 was Morningside Venture Investments Ltd's most active year for disposing of shares, totalling 36 transactions. Morningside Venture Investments Ltd's most active month to dispose stocks was the month of December. 2020 saw Morningside Venture Investments Ltd paying a total of $29,879,980.00 for 4,340,540 shares, this is the most they've acquired in one year. In 2022 Morningside Venture Investments Ltd cashed out on 38,189,081 shares for a total of $20,461,314.78, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
